Eldecalcitol

Eldecalcitol
Clinical data
Trade names	Edirol
ATC code	None;
Identifiers
	IUPAC name (1S,2S,3S,5Z,7E)-2-(3-Hydroxypropoxy)-9,10-secocholesta-5,7,10-triene-1,3,25-triol;
CAS Number	104121-92-8;
PubChem CID	6438982;
ChemSpider	4943418;
UNII	I2JP8UE90H;
Chemical and physical data
Formula	C30H50O5
Molar mass	490.725 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O[C@H]1CC(\C(=C)[C@H](O)[C@H]1OCCCO)=C\C=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CCCC(O)(C)C)C;
	InChI InChI=1S/C30H50O5/c1-20(9-6-15-29(3,4)34)24-13-14-25-22(10-7-16-30(24,25)5)11-12-23-19-26(32)28(27(33)21(23)2)35-18-8-17-31/h11-12,20,24-28,31-34H,2,6-10,13-19H2,1,3-5H3/b22-11+,23-12-/t20-,24-,25+,26+,27+,28+,30-/m1/s1; Key:FZEXGDDBXLBRTD-SJSKTVLPSA-N;

Eldecalcitol is an analog of calcitriol, the active form of vitamin D.

Commonly used in Japan for the treatment of osteoporosis. Osteoporosis is a common bone disease among the older generation, with an estimated prevalence of over 200 million people. This condition often results in bone fractures due to abnormally low bone mass density, and is a leading cause of disability, especially among developed countries with longer average life spans.